An Open, Randomised, Multicentre Clinical Study to Investigate the Safety and Efficacy of Steroid Withdrawal With Tacrolimus, Mycophenolate Mofetil and Daclizumab Against Tacrolimus, Mycophenolate Mofetil and Steroids in Children After Kidney Transplantation.

Trial Profile

An Open, Randomised, Multicentre Clinical Study to Investigate the Safety and Efficacy of Steroid Withdrawal With Tacrolimus, Mycophenolate Mofetil and Daclizumab Against Tacrolimus, Mycophenolate Mofetil and Steroids in Children After Kidney Transplantation.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Tacrolimus (Primary) ; Corticosteroids; Daclizumab; Mycophenolate mofetil
  • Indications Renal transplant rejection
  • Focus Pharmacodynamics
  • Acronyms TWIST
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 01 Apr 2010 Results published in American Journal of Transplantation.
    • 03 Jun 2009 Results reported at ATC 2009.
    • 20 Aug 2008 Actual study completion date added as 1 Feb 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top